Fennec Pharmaceuticals Inc FENC:NASDAQ

Last Price$6.94Cboe Real-Time Last Sale as of 3:33PM ET 8/10/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.25(3.74%)
Bid (Size)$6.92 (29)
Ask (Size)$7.00 (100)
Day Low / High$6.76 - 7.31
Volume112.6 K
  • Latest Stories
  • Commentary and Analysis
--Craig-Hallum Assumes Fennec Pharmaceuticals at Buy With $14 Price Target
9:46AM ET 8/08/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Fennec Pharmaceuticals Secures $45 Million Investment From Petrichor Healthcare
2:45PM ET 8/01/2022 MT Newswires

Fennec Pharmaceuticals (FENC) said Monday it has secured up to $45 million in investment from private equity firm Petrichor Healthcare Capital Management....

--Wedbush Lifts Price Target for Fennec Pharmaceuticals to $11 From $10, Maintains Outperform Rating
1:55PM ET 5/12/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Fennec Pharmaceuticals Q1 Net Loss Narrows
6:12AM ET 5/12/2022 MT Newswires

Fennec Pharmaceuticals (FENC) reported a Q1 net loss Thursday of $0.14 per diluted share, narrowing from a $0.18 loss a year earlier. Two analysts polled...

Fennec Pharmaceuticals Resubmits New Drug Application for Pedmark
6:24AM ET 3/24/2022 MT Newswires

Fennec Pharmaceuticals (FENC) said Thursday it has resubmitted its new drug application for Pedmark to the US Food and Drug Administration. Pedmark is a...

--Wedbush Lifts Price Target for Fennec Pharmaceuticals to $10 From $9, Maintains Outperform Rating
2:02PM ET 2/28/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Fennec Pharmaceuticals Chief Commercial Officer Resigns
6:06AM ET 1/31/2022 MT Newswires

Fennec Pharmaceuticals (FENC) said Monday that Chief Commercial Officer Shubh Goel has resigned and will leave the company in late February. ...

--Maxim Group Adjusts Price Target on Fennec Pharmaceuticals to $10 From $12, Keeps Buy Rating
9:35AM ET 12/01/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Craig-Hallum Adjusts Price Target on Fennec Pharmaceuticals to $14 From $19, Maintains Buy Rating
10:31AM ET 11/30/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

--Wedbush Adjusts Price Target on Fennec Pharmaceuticals to $9 From $12 on Pedmark Approval Delay; Outperform Rating Kept
9:38AM ET 11/29/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...